NO175746C - Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd

Info

Publication number
NO175746C
NO175746C NO904034A NO904034A NO175746C NO 175746 C NO175746 C NO 175746C NO 904034 A NO904034 A NO 904034A NO 904034 A NO904034 A NO 904034A NO 175746 C NO175746 C NO 175746C
Authority
NO
Norway
Prior art keywords
phenoxatine
dioxide
ethyl
preparation
therapeutically active
Prior art date
Application number
NO904034A
Other languages
English (en)
Norwegian (no)
Other versions
NO904034D0 (no
NO904034L (no
NO175746B (no
Inventor
Morton Harfenist
Daniel Peter Claude Mcgee
Helen Lyng White
Barrett Randolph Cooper
Jonathan Robert Tolmi Davidson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO904034D0 publication Critical patent/NO904034D0/no
Publication of NO904034L publication Critical patent/NO904034L/no
Publication of NO175746B publication Critical patent/NO175746B/no
Publication of NO175746C publication Critical patent/NO175746C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D327/00Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06Six-membered rings
    • C07D327/08[b,e]-condensed with two six-membered carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO904034A 1989-09-18 1990-09-17 Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd NO175746C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898921069A GB8921069D0 (en) 1989-09-18 1989-09-18 Pharmaceutically active compound,preparation and use

Publications (4)

Publication Number Publication Date
NO904034D0 NO904034D0 (no) 1990-09-17
NO904034L NO904034L (no) 1991-03-19
NO175746B NO175746B (no) 1994-08-22
NO175746C true NO175746C (no) 1994-11-30

Family

ID=10663238

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904034A NO175746C (no) 1989-09-18 1990-09-17 Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd

Country Status (18)

Country Link
US (1) US5420156A (fr)
EP (1) EP0419157A3 (fr)
JP (1) JPH03145486A (fr)
KR (1) KR940000074B1 (fr)
AU (1) AU643701B2 (fr)
CA (1) CA2025524A1 (fr)
DD (1) DD295840A5 (fr)
FI (1) FI88794C (fr)
GB (1) GB8921069D0 (fr)
HU (1) HU207065B (fr)
IE (1) IE903355A1 (fr)
IL (1) IL95709A (fr)
MC (1) MC2152A1 (fr)
MX (1) MX9203221A (fr)
NO (1) NO175746C (fr)
NZ (1) NZ235343A (fr)
PT (1) PT95327A (fr)
ZA (1) ZA907398B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921069D0 (en) * 1989-09-18 1989-11-01 Wellcome Found Pharmaceutically active compound,preparation and use
CA2091685A1 (fr) * 1990-09-17 1992-03-18 Daniel Peter Claude Mcgee Derives de la phenoxathiine 1 de substitution utilises comme antidepresseurs
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US6110961A (en) * 1996-09-11 2000-08-29 Krenitsky Pharmaceuticals, Inc. Phenoxathin derivatives as inhibitors of monoamine oxidase

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997422A (en) * 1959-01-09 1961-08-22 Smith Kline French Lab Monoamine oxidase inhibition
AU2843377A (en) * 1972-05-19 1979-03-08 Wellcome Found Phenoxathiin dioxides
GB1447032A (en) * 1972-05-19 1976-08-25 Wellcome Found Tricyclic sulphones and pharmaceutical compositions containing them
US4091108A (en) * 1972-09-06 1978-05-23 Burroughs Wellcome Co. Antiallergic pharmaceutical composition and use
FR2239025B1 (fr) * 1973-07-25 1982-07-02 Souriau & Cie
DE2339617A1 (de) * 1973-08-04 1975-02-20 Merck Patent Gmbh Sulfoxide und sulfone sowie verfahren zu ihrer herstellung
US4012517A (en) * 1975-01-24 1977-03-15 Burroughs Wellcome Co. Compositions and treatment
EP0068563A3 (fr) * 1981-06-23 1983-06-15 THE PROCTER & GAMBLE COMPANY Dérivés d'acide acétique hétérocycliques et compositions pour le traitement des affections osseuses
EP0150891A1 (fr) * 1984-01-05 1985-08-07 The Wellcome Foundation Limited Composés tricycliques, procédés pour leur préparation, compositions les contenant et leur usage en médecine
EP0270252A3 (fr) * 1986-11-11 1990-04-04 Imperial Chemical Industries Plc Dérivés d'acides propénoiques utilisés en agriculture
JPH01294718A (ja) * 1987-12-15 1989-11-28 Nippon Oil & Fats Co Ltd 新規な透明樹脂、高屈折率透明光学用樹脂、塗料用樹脂及び単量体
GB8921069D0 (en) * 1989-09-18 1989-11-01 Wellcome Found Pharmaceutically active compound,preparation and use

Also Published As

Publication number Publication date
JPH03145486A (ja) 1991-06-20
CA2025524A1 (fr) 1991-03-19
MC2152A1 (fr) 1992-03-10
NO904034D0 (no) 1990-09-17
HU207065B (en) 1993-03-01
EP0419157A2 (fr) 1991-03-27
PT95327A (pt) 1991-05-22
ZA907398B (en) 1992-05-27
HUT58068A (en) 1992-01-28
US5420156A (en) 1995-05-30
MX9203221A (es) 1992-07-01
FI88794C (fi) 1993-07-12
AU643701B2 (en) 1993-11-25
NZ235343A (en) 1992-08-26
DD295840A5 (de) 1991-11-14
KR940000074B1 (ko) 1994-01-05
NO904034L (no) 1991-03-19
IL95709A (en) 1995-03-30
EP0419157A3 (en) 1991-08-28
FI904560A0 (fi) 1990-09-17
KR910006270A (ko) 1991-04-29
GB8921069D0 (en) 1989-11-01
NO175746B (no) 1994-08-22
AU6265390A (en) 1991-03-21
HU905928D0 (en) 1991-03-28
IE903355A1 (en) 1991-04-10
FI88794B (fi) 1993-03-31

Similar Documents

Publication Publication Date Title
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO179639C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO891191D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater.
NO175714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere
NO177096C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
NO174391C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174892C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser
FI884660A (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
NO174422C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive kromanderivater
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI901883A0 (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
FI100799B (fi) Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi
NO175746C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt 1-etyl-fenoksatiin-10,10-dioksyd